Treatment of multiple sclerosis using a population of CD19 car-expressing cells

TW202635349APending Publication Date: 2026-09-01NOVARTIS AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114141427
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-28
Filing Date
2025-10-27
Publication Date
2026-09-01

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

The invention provides methods of using a population of CD19 CAR-expressing cells (for example, rapcabtagene autoleucel) for treating neuroimmune diseases or disorders. Also disclosed are methods of making a population of CD19 CAR-expressing cells.
Need to check novelty before this filing date? Find Prior Art